Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Intravenous nicotine in Alzheimer's disease: a pilot study.

Newhouse PA, Sunderland T, Tariot PN, Blumhardt CL, Weingartner H, Mellow A, Murphy DL.

Psychopharmacology (Berl). 1988;95(2):171-5.

PMID:
3137593
2.

Nicotine patches in Alzheimer's disease: pilot study on learning, memory, and safety.

Wilson AL, Langley LK, Monley J, Bauer T, Rottunda S, McFalls E, Kovera C, McCarten JR.

Pharmacol Biochem Behav. 1995 Jun-Jul;51(2-3):509-14.

PMID:
7667377
3.

Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer's disease.

White HK, Levin ED.

Psychopharmacology (Berl). 1999 Apr;143(2):158-65.

PMID:
10326778
4.

The effects of nicotine in dermal plaster on cognitive functions in patients with Alzheimer's disease.

Snaedal J, Johannesson T, Jonsson JE, Gylfadottir G.

Dementia. 1996 Jan-Feb;7(1):47-52.

PMID:
8788082
5.

Neuroendocrine, physiologic, and behavioral responses following intravenous nicotine in nonsmoking healthy volunteers and in patients with Alzheimer's disease.

Newhouse PA, Sunderland T, Narang PK, Mellow AM, Fertig JB, Lawlor BA, Murphy DL.

Psychoneuroendocrinology. 1990;15(5-6):471-84.

PMID:
1966302
6.

Acute effects of high-dose thyrotropin releasing hormone infusions in Alzheimer's disease.

Mellow AM, Sunderland T, Cohen RM, Lawlor BA, Hill JL, Newhouse PA, Cohen MR, Murphy DL.

Psychopharmacology (Berl). 1989;98(3):403-7.

PMID:
2501817
7.

Nicotine therapy in patients with Alzheimer's disease.

Baldinger SL, Schroeder DJ.

Ann Pharmacother. 1995 Mar;29(3):314-5. Review.

PMID:
7606080
9.

Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease.

Eriksdotter Jönhagen M, Nordberg A, Amberla K, Bäckman L, Ebendal T, Meyerson B, Olson L, Seiger, Shigeta M, Theodorsson E, Viitanen M, Winblad B, Wahlund LO.

Dement Geriatr Cogn Disord. 1998 Sep-Oct;9(5):246-57.

PMID:
9701676
10.

Multiple-dose arecoline infusions in Alzheimer's disease.

Tariot PN, Cohen RM, Welkowitz JA, Sunderland T, Newhouse PA, Murphy DL, Weingartner H.

Arch Gen Psychiatry. 1988 Oct;45(10):901-5.

PMID:
3048224
12.

Differential responsivity of mood, behavior, and cognition to cholinergic agents in elderly neuropsychiatric populations.

Sunderland T, Tariot PN, Newhouse PA.

Brain Res. 1988 Dec;472(4):371-89. Review.

PMID:
3066441
13.

Nicotinic systems in central nervous systems disease: degenerative disorders and beyond.

Newhouse PA, Kelton M.

Pharm Acta Helv. 2000 Mar;74(2-3):91-101. Review.

PMID:
10812945
14.

Cognition-enhancing effect of vagus nerve stimulation in patients with Alzheimer's disease: a pilot study.

Sjögren MJ, Hellström PT, Jonsson MA, Runnerstam M, Silander HC, Ben-Menachem E.

J Clin Psychiatry. 2002 Nov;63(11):972-80.

PMID:
12444809
15.

Safety and tolerability of donepezil at doses up to 20 mg/day: results from a pilot study in patients with Alzheimer's disease.

Doody RS, Corey-Bloom J, Zhang R, Li H, Ieni J, Schindler R.

Drugs Aging. 2008;25(2):163-74.

PMID:
18257603
16.

A pilot study of clonidine plus physostigmine in Alzheimer's disease.

Bierer LM, Aisen PS, Davidson M, Ryan TM, Schmeidler J, Davis KL.

Dementia. 1994 Sep-Oct;5(5):243-6.

PMID:
7951680
17.

Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer's disease: results of a placebo-controlled, double-blind, pilot study.

Asthana S, Craft S, Baker LD, Raskind MA, Birnbaum RS, Lofgreen CP, Veith RC, Plymate SR.

Psychoneuroendocrinology. 1999 Aug;24(6):657-77.

PMID:
10399774
18.

NGF and the treatment of Alzheimer's disease.

Olson L.

Exp Neurol. 1993 Nov;124(1):5-15. Review.

PMID:
8282080
19.

Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion.

Alvarez XA, Mouzo R, Pichel V, Pérez P, Laredo M, Fernández-Novoa L, Corzo L, Zas R, Alcaraz M, Secades JJ, Lozano R, Cacabelos R.

Methods Find Exp Clin Pharmacol. 1999 Nov;21(9):633-44.

PMID:
10669911
20.
Items per page

Supplemental Content

Write to the Help Desk